traditional risk factors and adds to the growing body of information on biomarkers that may be used to determine the risk of major cardiovascular disease in asymptomatic individuals.
"While prior studies have recognized the importance of so-called vulnerable plaque in heralding cerebrovascular disease, much of that work was based on autopsy data or on patients with clinically significant carotid stenosis," said Herbert Y. Kressel, M.D., editor of Radiology. "This large, prospective, multicenter study has clearly shown that these findings can be recognized in asymptomatic individuals and can be predictive of longer term outcomes as well." Cardiovascular events occurred in 59 of the patients in the study. Abnormal thickening of the carotid artery wall and the presence of a lipid core and calcium in the internal carotid artery on MRI were significant predictors of subsequent events. A lipid core was present in almost half of the patients who had an event, compared with only 17.8 percent of those who did not have an event.
"The results of our study bolster the use of MRI as a surrogate marker of efficacy in therapeutic studies and point to a role in determining which patients might need more aggressive treatments," Dr. Bluemke said. "As risk factor prediction gets better, we'll be able to screen more intelligently and use more intensive treatments in those individuals who face a higher risk of cardiovascular events." The Radiological Society of North America (RSNA) is an association of more than 54,000 radiologists, radiation oncologists, medical physicists and related scientists, promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)
